Company Search:
Advanced Search
Sponsored Links
Arbutus Biopharma Corp Company Snapshot
Arbutus Biopharma Corp operates within the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Arbutus Biopharma Corp with three other companies in this sector in CANADA : Antibe Therapeutics Inc (2019 sales of 9.54 million Canadian Dollars [US$7.51 million] ), Pond Technologies Holdings Inc (6.14 million Canadian Dollars [US$4.83 million] of which 58% was Nutraceutical Products), and Liminal BioSciences Inc (4.90 million Canadian Dollars [US$3.86 million] of which 97% was Plasma derived therapeutics).

Sales Analysis. During the year ended December of 2019, sales at Arbutus Biopharma Corp were C$7.95 million (US$6.26 million). This is an increase of 3.0% versus 2018, when the company's sales were C$7.73 million. Despite this increase, sales are still well below the level achieved in 2017, when Arbutus Biopharma Corp reported sales of C$13.86 million.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Arbutus Biopharma Corp
  Stock Performance Chart for Arbutus Biopharma Corp
  Stock Data: Recent Stock Performance:
  Current Price (1/8/2021): 4.91
(Figures in Canadian Dollars)
1 Week 8.6%   13 Weeks -1.7%  
4 Weeks 16.9%   52 Weeks 24.1%  
Arbutus Biopharma Corp Key Data:
  Ticker: ABUS Country: Canada
  Exchanges: NAS Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2019 Sales 7,953,695
(Year Ending Jan 2020).
Employees: 80
  Currency: Canadian Dollars Market Cap: 415,236,886
  Fiscal Yr Ends: December Shares Outstanding: 84,618,575
  Share Type: Common Closely Held Shares: 24,012,619
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.